Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: Results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non-cancer pain
Titel:
Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: Results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non-cancer pain
Auteur:
Webster, Lynn Jansen, Jan Peter Peppin, John Lasko, Ben Irving, Gordon Morlion, Bart Snidow, Jerry Pierce, Amy Mortensen, Eric Kleoudis, Christi Carter, Eric